News for Verrica Pharmaceuticals Inc Stock (VRCA)

VERRICA PHARMACEUTICALS INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of Pennsylvania against Verrica Pharmac

PRNewsWire • 06/15/22

ROSEN, National Trial Lawyers, Encourages Verrica Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - VRCA

Newsfile Corp • 06/14/22

VRCA Investor Update: Robbins LLP Reminds Investors of Class Action Against Verrica Pharmaceuticals Inc. (VRCA)

Business Wire • 06/13/22

Here's Why Verrica Pharmaceuticals Inc. (VRCA) Could be Great Choice for a Bottom Fisher

Zacks Investment Research • 06/13/22

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)

Business Wire • 06/13/22

Stockholder Alert: Robbins LLP Informs Investors of Class Action Against Verrica Pharmacuticals Inc. (VRCA)

Business Wire • 06/11/22

Bronstein, Gewirtz & Grossman, LLC Notifies Verrica Pharmaceuticals Inc. (VRCA) Investors of Class Action and Encourages Investors to Contact the Firm

PRNewsWire • 06/10/22

VRCA Stockholder News: Robbins LLP Investigates Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Stockholders

Business Wire • 06/10/22

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)

Business Wire • 06/09/22

EQUITY ALERT: Rosen Law Firm Encourages Verrica Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – VRCA

Business Wire • 06/08/22

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Verrica Pharmaceuticals, Inc. (VRCA) Investors

Business Wire • 06/08/22

VERRICA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Verrica Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Business Wire • 06/08/22

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Verrica Pharmaceuticals Inc. (VRCA) Investors

Business Wire • 06/07/22

VRCA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Verrica Pharmaceuticals Inc.

Business Wire • 06/06/22

Here's Why Verrica Pharmaceuticals Inc. (VRCA) is Poised for a Turnaround After Losing 70.4% in 4 Weeks

Zacks Investment Research • 06/01/22

VERRICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Verrica Pharmaceuticals, Inc. on Behalf of Verrica Stockholders and Encourages Investors to Contact the Firm

Business Wire • 05/31/22

Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of Verrica Pharmaceuticals Inc. (VRCA) Investors

Business Wire • 05/27/22

Verrica (VRCA) Down 64% as Molluscum Drug Gets CRL From FDA

Zacks Investment Research • 05/26/22

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors

Business Wire • 05/26/22

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors

Business Wire • 05/26/22

The Law Offices of Frank R. Cruz Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors

Business Wire • 05/26/22

6 Stocks Halted In Wednesday's Session: Here's Why

Benzinga • 05/25/22

RBC Capital Slashes Verrica's Price Target After Third Rejection - What's Next?

Benzinga • 05/25/22

Why Is Verrica Pharmaceuticals (VRCA) Stock Plunging 55% Today?

InvestorPlace • 05/25/22

Verrica's stock slides after getting second complete response letter from FDA

Market Watch • 05/25/22